Stage IV Breast Cancer AJCC v6 and v7

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma Trial in United States (Laboratory

Active, not recruiting
  • Locally Advanced Breast Carcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +3 more
Jan 31, 2023

Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6 Trial in Puerto Rico, United States

Active, not recruiting
  • Invasive Breast Carcinoma
  • +3 more
  • Bevacizumab
  • +4 more
  • Mobile, Alabama
  • +525 more
Jan 28, 2023

HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive Trial in United States (procedure, drug,

Active, not recruiting
  • HER2/Neu Negative
  • +3 more
  • Computed Tomography
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 27, 2023

Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Bone
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 4, 2023

Blood and Tumor Samples From Advanced or Metastatic Estrogen

Active, not recruiting
  • Advanced Breast Carcinoma
  • +8 more
  • Biopsy
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 3, 2023

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

Recruiting
  • BRCA1 Gene Mutation
  • +19 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • New Brunswick, New Jersey
  • +1 more
Nov 16, 2022

Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States (drug, other, biological)

Suspended
  • Metastatic Breast Carcinoma
  • Stage IV Breast Cancer AJCC v6 and v7
  • Corona, California
  • +6 more
Sep 28, 2022

Malignant Digestive System Tumor, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma Trial in Houston (procedure,

Recruiting
  • Malignant Digestive System Neoplasm
  • +12 more
  • Computed Tomography
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

Terminated
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +12 more
  • Laboratory Biomarker Analysis
  • ROR1 CAR-specific Autologous T-Lymphocytes
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

Metastatic BRCA-Associated Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in

Active, not recruiting
  • Metastatic BRCA-Associated Breast Carcinoma
  • +5 more
  • Anchorage, Alaska
  • +815 more
Aug 5, 2022

Locally Advanced Unresectable Breast Carcinoma, Metastatic Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in United

Suspended
  • Locally Advanced Unresectable Breast Carcinoma
  • +3 more
  • Phoenix, Arizona
  • +57 more
Jul 27, 2022

HER2-Positive Breast Carcinoma, Invasive Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Canada, Korea,

Completed
  • HER2-Positive Breast Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +301 more
Jun 28, 2022

Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)

Active, not recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Duarte, California
  • +4 more
Jul 16, 2022

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

Active, not recruiting
  • Androgen Receptor Positive
  • +5 more
  • Corona, California
  • +6 more
Jun 8, 2022

Breast Adenocarcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Eribulin Mesylate, Laboratory

Suspended
  • Breast Adenocarcinoma
  • +4 more
  • Eribulin Mesylate
  • +3 more
  • Scottsdale, Arizona
  • +38 more
May 25, 2022

Collecting Blood Samples From and Without Cancer to Evaluate

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +61 more
  • Questionnaire Administration
  • Biospecimen Collection
  • (no location specified)
Apr 12, 2022

Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma Trial in Canada,

Recruiting
  • Breast Adenocarcinoma
  • +8 more
  • Birmingham, Alabama
  • +667 more
Apr 6, 2022

Breast Adenocarcinoma, Metastatic Triple-Negative Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Breast Adenocarcinoma
  • +6 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 14, 2021

Breast Adenocarcinoma, HER2/Neu Negative, Locally Advanced Breast Carcinoma Trial in South Africa, United States (Entinostat,

Active, not recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Birmingham, Alabama
  • +662 more
Oct 18, 2021

Estrogen Receptor-positive Breast Cancer, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +2 more
  • Anchorage, Alaska
  • +446 more
Sep 17, 2021

Collecting, Analyzing, and Storing Samples From Metastatic,

Terminated
  • Estrogen Receptor Negative
  • +4 more
  • Cytology Specimen Collection Procedure
  • +3 more
  • Seattle, Washington
  • +1 more
Sep 23, 2021

Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7 Trial in United States (Endoxifen

Active, not recruiting
  • Recurrent Breast Carcinoma
  • +5 more
  • Endoxifen Hydrochloride
  • +3 more
  • Mobile, Alabama
  • +566 more
Sep 1, 2021